Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

MBX Biosciences (MBX) Return on Capital Employed (2024 - 2026)

MBX Biosciences has reported Return on Capital Employed over the past 3 years, most recently at 24.43% for Q1 2026.

  • Quarterly results put Return on Capital Employed at 24.43% for Q1 2026, up 856.0% from a year ago — trailing twelve months through Mar 2026 was 24.43% (up 856.0% YoY), and the annual figure for FY2025 was 31.49%, up 976.0%.
  • Return on Capital Employed reached 24.43% in Q1 2026 per MBX's latest filing, up from 26.0% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 24.43% in Q1 2026 and bottomed at 38.14% in Q2 2025.
  • Median Return on Capital Employed over the past 3 years was 27.96% (2025), compared with a mean of 29.54%.
  • The largest annual shift saw Return on Capital Employed fell -21bps in 2025 before it skyrocketed 856bps in 2026.
  • Over 3 years, Return on Capital Employed stood at 25.79% in 2024, then decreased by -1bps to 26.0% in 2025, then grew by 6bps to 24.43% in 2026.
  • Business Quant data shows Return on Capital Employed for MBX at 24.43% in Q1 2026, 26.0% in Q4 2025, and 29.92% in Q3 2025.